GLUT1 deficiency syndrome
GLUT1 Deficiency Syndrome GLUT1 Deficiency Syndrome (GLUT1DS) is a rare genetic disorder that affects the brain's ability to utilize glucose, leading to a variety of neurological symptoms. This condition is caused by mutations in the SLC2A1 gene, which encodes the glucose transporter protein type 1 (GLUT1).
Overview[edit | edit source]
GLUT1DS is characterized by a deficiency in the GLUT1 protein, which is responsible for transporting glucose across the blood-brain barrier. This deficiency results in insufficient glucose supply to the brain, leading to energy deficits and neurological dysfunction.
Symptoms[edit | edit source]
The symptoms of GLUT1DS can vary widely among individuals but often include:
- Seizures: Often the first symptom to appear, typically starting in infancy.
- Developmental Delay: Delays in reaching developmental milestones.
- Movement Disorders: Such as ataxia, dystonia, and spasticity.
- Microcephaly: A smaller than normal head size.
- Cognitive Impairment: Ranging from mild learning disabilities to severe intellectual disability.
Diagnosis[edit | edit source]
Diagnosis of GLUT1DS is based on clinical evaluation, genetic testing, and laboratory tests such as:
- Lumbar Puncture: To measure glucose levels in the cerebrospinal fluid (CSF), which are typically low in GLUT1DS.
- Genetic Testing: Identification of mutations in the SLC2A1 gene.
Treatment[edit | edit source]
There is no cure for GLUT1DS, but treatment focuses on managing symptoms and providing the brain with an alternative energy source:
- Ketogenic Diet: A high-fat, low-carbohydrate diet that provides ketones as an alternative fuel for the brain.
- Antiepileptic Drugs: To control seizures, although they may be less effective than dietary therapy.
Prognosis[edit | edit source]
The prognosis for individuals with GLUT1DS varies. Early diagnosis and treatment with a ketogenic diet can improve outcomes, but some individuals may continue to experience neurological challenges.
Research[edit | edit source]
Ongoing research is focused on better understanding the pathophysiology of GLUT1DS, developing new treatments, and improving diagnostic methods.
See Also[edit | edit source]
External Links[edit | edit source]
NIH genetic and rare disease info[edit source]
GLUT1 deficiency syndrome is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD